Go Pro

EFG International AG Takes $1.63 Million Position in The Clorox Company $CLX

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • EFG International AG acquired 17,070 Clorox shares worth approximately $1.63 million in the second quarter. Institutional investors and hedge funds collectively own 78.53% of CLX.
  • Analysts remain cautious, with 12 Hold ratings and five Sell ratings; Clorox has an average “Reduce” rating and a consensus price target of $102.40.
  • Clorox surpassed quarterly earnings and revenue expectations, but revenue declined 2% year over year. The company raised its quarterly dividend to $1.25 per share, implying a 4.8% annualized yield.
  • MarketBeat previews top five stocks to own in September.

EFG International AG acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 17,070 shares of the company's stock, valued at approximately $1,629,000.

Other institutional investors have also made changes to their positions in the company. Darwin Wealth Management LLC acquired a new position in shares of Clorox in the 2nd quarter worth approximately $29,000. Caitlin John LLC boosted its stake in Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company's stock valued at $27,000 after buying an additional 253 shares in the last quarter. Ancora Advisors LLC bought a new stake in Clorox in the second quarter valued at $28,000. Avalon Trust Co bought a new stake in Clorox in the second quarter valued at $29,000. Finally, Root Financial Partners LLC raised its stake in Clorox by 83.8% during the first quarter. Root Financial Partners LLC now owns 318 shares of the company's stock worth $33,000 after acquiring an additional 145 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently commented on CLX. Wells Fargo & Company boosted their target price on shares of Clorox from $95.00 to $102.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 4th. Citigroup increased their target price on shares of Clorox from $97.00 to $100.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft set a $98.00 price target on shares of Clorox in a research report on Tuesday, August 4th. BNP Paribas Exane cut their target price on shares of Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research note on Monday, July 20th. Finally, Morgan Stanley decreased their price target on Clorox from $110.00 to $97.00 and set an "equal weight" rating on the stock in a research report on Friday, May 1st. Twelve equities research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Reduce" and an average target price of $102.40.

Get Our Latest Stock Analysis on Clorox

Clorox Stock Down 0.6%

Shares of CLX opened at $104.33 on Thursday. The business's fifty day moving average price is $99.54 and its two-hundred day moving average price is $102.83. The firm has a market capitalization of $12.62 billion, a price-to-earnings ratio of 21.65, a PEG ratio of 3.28 and a beta of 0.54. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $128.90. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the previous year, the company posted $2.87 earnings per share. The firm's quarterly revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, analysts predict that The Clorox Company will post 5.8 earnings per share for the current year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be issued a dividend of $1.25 per share. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 annualized dividend and a yield of 4.8%. This is an increase from Clorox's previous quarterly dividend of $1.24. Clorox's dividend payout ratio (DPR) is presently 103.73%.

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines